Table 1 Baseline demographic and clinical characteristics
Baseline variables | Total sample (n = 255) | Intervention (n = 127) | Control (n = 128) |
|---|---|---|---|
Mean age (SD), years | 54.6 (8.1) | 54.6 (8.7) | 54.5 (7.6) |
Sex | |||
 Female | 103 (40%) | 47 (37%) | 56 (44%) |
 Current employed | 169 (67%) | 84 (67%) | 85 (66%) |
Education level | |||
 Primary school | 37 (15%) | 18 (15%) | 19 (15%) |
 High school | 110 (45%) | 62 (50%) | 48 (39%) |
 College | 99 (40%) | 43 (35%) | 56 (46%) |
 Current smokers | 78 (31%) | 39 (31%) | 39 (31%) |
 Metabolic syndrome | 155 (67%) | 80 (67%) | 75 (67%) |
 Diabetes mellitus | 42 (17%) | 21 (16%) | 21 (17%) |
Mean blood pressure (SD) | |||
 Systolic (mmHg) | 133 (14) | 132 (14) | 133 (15) |
 Diastolic (mmHg) | 84 (10) | 83 (10) | 85 (10) |
Mean blood values (SD) | |||
 Total cholesterol (mmol/l) | 5.16 (1.11) | 5.10 (1.08) | 5.23 (1.14) |
 LDL-cholesterol (mmol/l) | 3.23 (0.99) | 3.12 (1.00) | 3.35 (0.96) |
 HDL-cholesterol (mmol/l) | 1.21 (0.39) | 1.19 (0.42) | 1.24 (0.36) |
 Triglycerides (mmol/l) | 1.72 (1.32) | 1.90 (1.70) | 1.53 (0.68) |
 Fasting blood glucose (mmol/l) | 6.49 (1.62) | 6.52 (1.64) | 6.46 (1.60) |
 HbA1c (%) | 5.99 (0.81) | 6.03 (0.85) | 5.95 (0.78) |
 Insulin (pmol/l) | 100.42 (102.16) | 97.91 (70.21) | 103.12 (128.14) |
 ApoA1 (g/l) | 1.48 (0.29) | 1.46 (0.29) | 1.49 (0.29) |
 ApoB (g/l) | 1.01 (0.27) | 1.00 (0.29) | 1.01 (0.24) |
 hsCRP (mg/l) | 3.05 (3.30) | 2.99 (3.21) | 3.12 (3.39) |
 Waist circumference (SD), cm | 106.7 (14.1) | 106.8 (13.6) | 106.7 (14.8) |
  Men | 110.4 (12.5) | 109.4 (12.2) | 111.6 (12.9) |
  Women | 101.3 (14.7) | 102.4 (14.7) | 100.2 (14.8) |
 BMI (SD),kg/m2 | 30.9 (5.4) | 30.9 (5.2) | 30.9 (5.6) |
  Men | 31.4 (5.0) | 31.0 (4.8) | 31.8 (5.1) |
  Women | 30.1 (5.9) | 30.7 (5.7) | 29.6 (6.0) |
 Weight (SD), kg | 93.8 (20.7) | 93.4 (19.4) | 94.3 (22.2) |
  Men | 101.7 (18.9) | 99.9 (18.4) | 103.8 (19.4) |
  Women | 82.1 (17.7) | 82.6 (16.0) | 81.6 (19.3) |
Cardiovascular medication | |||
 Antihypertensive drugs | 134 (52.5%) | 67 (52.8%) | 67 (52.3%) |
 Lipid-lowering drugs | 94 (36.9%) | 53 (41.7%) | 41 (32.0%) |
 Antidiabetic medication | 29 (11.4%) | 16 (12.6%) | 13 (10.2%) |